Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 28, 2014; 20(36): 13071-13078
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.13071
NANOG: A promising target for digestive malignant tumors
Ai-Xi Sun, Chang-Jiang Liu, Zi-Qin Sun, Zhi Wei
Ai-Xi Sun, Chang-Jiang Liu, Zi-Qin Sun, Zhi Wei, Department of Gastroenterology, The General Hospital of Jinan Military Command, Jinan 250031, Shandong Province, China
Author contributions: Sun AX and Liu CJ equally contributed to this paper; Liu CJ designed the article; Sun ZQ designed and revised the paper; Sun AX wrote the paper; Wei Z revised the paper.
Supported by Natural Science Foundation of Shandong Province, No. ZR2011HM021
Correspondence to: Zi-Qin Sun, MD, PhD, Department of Gastroenterology, The General Hospital of Jinan Military Command, No. 25 Shifan Road, Tianqiao District, Jinan 250031, Shandong Province, China. ziqins@126.com
Telephone: +86-531-51665320 Fax: +86-531-51665254
Received: February 14, 2014
Revised: May 3, 2014
Accepted: June 13, 2014
Published online: September 28, 2014
Core Tip

Core tip: This review article differs from previous reviews by concentrating on the relationship between NANOG and cancer. This review contains the following five sections: the structure of NANOG, NANOG and cancer stem cells, signal pathways associated with NANOG in cancer, NANOG in specific human tumors, and the role of NANOG in anti-cancer therapy. Each section contains novel insights and comprehensively reviews the current literature, which will be very useful to the journal’s readers.